Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Benitec Biopharma Inc. BNTC

Full chart Compare

Set alert

9.87 USD +0.33 (+3.46%)

At closeNov 9, 2026, 4:00 PM EST

9.90 +0.03 +0.30%

After hours · Nov 9, 4:00 PM ET

9.29 Day range 10.22

7.89 52-week range 14.39

YTD: -26.73%
1 year: -22.83%

News

1 week ago benzinga.com Benitec Biopharma Announces Its Interim Data From BB-301 Phase 1b/2a Trial Shows Continued Durable Enhancements In Participants Treated With Low Dose Of BB-301; 100% Response Rate Seen Across All Patients Treated Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "Company"), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary "Silence and
2 weeks ago benzinga.com This Guardant Health Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Analysts initiated coverage: VSE Sector Weight; Guardant, Quantum, Benitec and Diodes rated Buy/Overweight/Outperform with targets up to $200.
2 weeks ago benzinga.com Raymond James Initiates Coverage On Benitec Biopharma with Outperform Rating, Announces Price Target of $14 Raymond James analyst Tiago Fauth initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Outperform rating and announces Price Target of $14.